SB746 creates a new felony-level involuntary manslaughter offense for a person who knowingly and intentionally manufactures, sells, or distributes a controlled substance containing a detectable amount of fentanyl, and whose conduct unintentionally causes another person’s death. The bill specifies that the fentanyl-related drug transaction must be the proximate cause of death, regardless of when or where death occurs, and it removes as a defense the fact that the decedent voluntarily used the drug. It also sets venue rules allowing prosecution where the drug was made, sold, distributed, used, or where the death occurred.
The bill also revises Virginia’s overdose immunity law. It expands protections from arrest or prosecution for certain offenses when a person in good faith seeks emergency medical help, reports an overdose, or renders emergency aid such as CPR or naloxone administration. Those protections now expressly include the new involuntary manslaughter offense in limited circumstances, while preserving exceptions for searches, warrants, and arrests. The bill further provides that a person who only gave fentanyl as an accommodation, without profit or intent to induce use or addiction, is not guilty of involuntary manslaughter but is guilty of a Class 6 felony accommodation sale.
Impact
SB746 amends Virginia criminal law by adding a fentanyl-specific involuntary manslaughter statute and by conforming the state’s overdose immunity provisions to that new offense. It increases potential criminal exposure for fentanyl distribution cases that result in death, while preserving a lesser offense for noncommercial accommodation transfers. The bill also clarifies that a person who seeks emergency medical help or renders overdose aid is protected from arrest or prosecution for certain listed offenses, including the new manslaughter charge in specified circumstances. The fiscal note states the act may increase incarceration or commitment periods and assigns at least a $50,000 minimum fiscal impact.
Sentiment
The bill appears to have received broad overall support, passing both chambers with substantial margins and advancing through committee with favorable votes. The final enactment suggests general agreement with the policy goal of strengthening penalties for fentanyl-related deaths while preserving overdose-response immunity. At the same time, the recorded votes show some opposition at several stages, indicating that the measure was not unanimous and that some lawmakers had reservations about its scope or effects.
Contention
The main point of contention appears to have been the balance between tougher fentanyl homicide penalties and protections for people who seek emergency help during an overdose. Critics may have been concerned that expanding criminal liability could discourage bystanders or users from calling 911, while supporters likely viewed the bill as necessary to hold fentanyl distributors accountable for overdose deaths. The House and Senate also disagreed at one point over a substitute version, and the Senate later rejected the Governor’s recommendation, showing that the precise wording and policy tradeoffs were debated even though the bill ultimately became law.
Controlled substances: penalties; conduct associated with qualified psychoactive substances; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.).
Drug Testing for Welfare Recipients Act This bill requires the Temporary Assistance for Needy Families program, the Supplemental Nutrition Assistance Program, and specified public housing programs to subject individuals to substance-abuse screening and to deny benefits for individuals who test positive for a controlled substance.